Adjunctive use of methylphenidate in the treatment of psychotic unipolar depression

Clinical Neuropharmacology

Volumn 31, Issue 4, 2008, Pages 245-247

  Huang, Chang Chih ^a   Shiah, I Shin ^a,b   Chen, Hsing Kang ^a   Mao, Wei Chung ^a   Yeh, Yi Wei ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Methylphenidate; Psychosis; Psychostimulants; Unipolar depression

Indexed keywords

ALPRAZOLAM; BENZODIAZEPINE DERIVATIVE; LORAZEPAM; METHYLPHENIDATE; OLANZAPINE; VENLAFAXINE; ZOLPIDEM; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CENTRAL STIMULANT AGENT; CYCLOHEXANOL DERIVATIVE; NEUROLEPTIC AGENT;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; BLOOD ANALYSIS; CASE REPORT; CLINICAL FEATURE; CLINICAL GLOBAL IMPRESSION SCALE; DEPRESSION; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG USE; DRUG WITHDRAWAL; ELECTROCARDIOGRAM; ELECTROCONVULSIVE THERAPY; EVENING DOSAGE; FEMALE; FOLLOW UP; HAMILTON SCALE; HANGING; HUMAN; MAJOR DEPRESSION; MOOD DISORDER; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; PSYCHOSIS; SUICIDE ATTEMPT; DOSE RESPONSE; DRUG COMBINATION; MIDDLE AGED; PSYCHOLOGICAL ASPECT; TREATMENT OUTCOME;

ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CENTRAL NERVOUS SYSTEM STIMULANTS; CYCLOHEXANOLS; DEPRESSIVE DISORDER; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; METHYLPHENIDATE; MIDDLE AGED; SUICIDE, ATTEMPTED; TREATMENT OUTCOME;

EID: 53449095932     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNF.0b013e318157d998     Document Type: Article

References (18)

1. Volkow ND. Stimulant medications: how to minimize their reinforcing effects? Am J Psychiatry 2006;163:359-361.
2. El-Mallakh RS. An open study of methylphenidate in bipolar depression. Bipolar Disord 2000;2:56-59.
3. Landman ME, Preisig R, Perlman M. A practical mood stimulant. J Med Soc NJ 1958;55:55-58.
4. Satel SL, Nelson JC. Stimulants in the treatment of depression: a critical overview. J Clin Psychiatry 1989;50:241-249.
5. Kaplitz SE. Withdrawn, apathetic geriatric patients responsive to methylphenidate. J Am Geriatr Soc 1975;23:271-276.
6. Mattes JA. Methylphenidate in mild depression: a double-blind controlled trial. J Clin Psychiatry 1985;46:525-527.
7. Orr K, Taylor D. Psychostimulants in the treatment of depression: a review of the evidence. CNS Drugs 2007;21:239-257.
8. Feinberg SS. Combining stimulants with monoamine oxidase inhibitors: a review of uses and one possible additional indication. J Clin Psychiatry 2004;65: 1520-1524.
9. Lavretsky H, Kim MD, Kumar A, et al. Combined treatment with methylphenidate and citalopram for accelerated response in the elderly: an open trial. J Clin Psychiatry 2003;64:1410-1414.
10. Lavretsky H, Kumar A. Methylphenidate augmentation of citalopram in elderly depressed patients. Am J Geriatr Psychiatry 2001;9:298-303.
11. Carlson PJ, Merlock MC, Suppes T. Adjunctive stimulant use in patients with bipolar disorder: treatment of residual depression and sedation. Bipolar Disord 2004;6:416-420.
12. Kaufmann MW, Cassem N, Murray G, et al. The use of methylphenidate in depressed patients after cardiac surgery. J Clin Psychiatry 1984;45:82-84.
13. Fernandez F, Adams F, Holmes VF, et al. Methylphenidate for depressive disorders in cancer patients. An alternative to standard antidepressants. Psychosomatics 1987;28:455-461.
14. Ghaemi SN. Treatment strategies for refractory unipolar depression. In: Ghaemi SN, ed. Mood Disorders: A Practice Guide. Philadelphia, PA: Lippincott Williams & Wilkins; 2003:106-125.
15. Konstantinidis A, Hrubos W, Nirnberger G, et al. Quetiapine in combination with citalopram in patients with unipolar psychotic depression. Prog Neuropsychopharmacol Biol Psychiatry 2007;31: 242-247.
16. Goto M, Yoshimura R, Kakihara S, et al. Risperidone in the treatment of psychotic depression. Prog Neuropsychopharmacol Biol Psychiatry 2006;30: 701-707.
17. Rothschild AJ, Williamson DJ, Tohen MF, et al. A double-blind, randomized study of olanzapine and olanzapine/fluoxetine combination for major depression with psychotic features. J Clin Psychopharmacol 2004;24:365-373.
18. Kindler S, Lustig M, Kotler M, et al. The role of psychostimulants in the treatment of depression. In: Nolen WA, Zohar J, Roose SP, Amsterdam JD, eds. Refractory Depression: Current Strategies and Future Directions. Chichester: John Wiley & Sons Ltd; 1994:147-154.